Combination of Netherton Syndrome and Hypopituitarism with Isolated Somatotropin Deficiency: Case Study

This case study discusses a patient with Netherton Syndrome, a genetic disorder characterized by ichthyosiform erythroderma, hair growth anomalies, and severe atopic dermatitis, who also presented with growth retardation and hypopituitarism with isolated somatotropin deficiency. The patient was treated with an IL-4/13 inhibitor, dupilumab, and somatotropin replacement therapy, resulting in significant improvement without clinically significant adverse effects. The study highlights the importance of investigating growth retardation causes in Netherton Syndrome patients and suggests that combining somatotropin therapy with dupilumab is effective and safe, requiring a multidisciplinary approach.